Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
San Mateo, East Bay, Palo Alto/Santa Cruz, Solano/Vallejo, San Francisco, Santa Rosa, Modesto, Greater Sacramento Valley
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
S1900K (LUNG-MAP SUB-STUDY): A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer